About ID Genomics

Building high-performance personalized diagnostics.

Our industry-leading team blends microbiology, biochemistry and molecular biology expertise with advanced product development know-how. We are creating genomic barcoding-based diagnostics that identify and track drug-resistant human pathogens.

Our Board of Directors

Evgeni Sokurenko, M.D., Ph.D.

Founder


Dr. Evgeni Sokurenko founded ID Genomics, Inc. and brings more than 25 years of experience leading, funding and carrying out microbiology, biochemistry and epidemiological research. He guides the company’s scientific direction and oversees its scientific collaborations. Dr. Sokurenko is a professor of Microbiology at the University of Washington, where he has served on the faculty since 1999. He has authored more than 100 peer-reviewed papers on bacterial pathogenesis and multi-drug resistance and is a co-inventor of ID Genomics’ technology.

Frederick Huntsberry


Frederick is a highly experienced C-level executive & strategic thinker with significant experience in finance and operations, most notably serving the entertainment, manufacturing & service industries in NA, Europe & Asia. Prior positions include the COO of Paramount Pictures and President of NBC Universal Television Distribution. Frederick currently serves as a Director on several Boards and brings his financial and operational wisdom to ID Genomics.

Mansour Samadpour, Ph.D.


Dr. Samadpour is the President of IEH Laboratories and Consulting Group (IEH), and Molecular Epidemiology, Inc. (MEI). He holds B.S. and M.S. degrees in Microbiology and a Ph.D. degree in Food Science and Technology and Molecular Biology from the University of Washington. After completing his Ph.D., Dr. Samadpour served as faculty at the University of Washington until 2003. In 2001, he founded IEH and MEI, which now have 130 ISO certified laboratories nationwide and are the largest players in the food and water safety testing industry.

Our Senior Executive Team

Linda Zuckerman, Ph.D.

President & C.E.O

LinkedIn

Linda Zuckerman, Ph.D. has spent over 15 years moving novel protein therapeutics, pharmaceuticals and medical devices from R&D through clinical trials and on to licensure with the FDA, EMA and other regulatory authorities. She has secured approvals for several biologics and medical devices, and her experience spans a broad range of indications, including oncology, autoimmunity and hemostasis.
As President and CEO of ID Genomics, Dr. Zuckerman now applies her extensive drug development expertise to the global health challenge of antibiotic resistance, with the ultimate goal of delivering rapid, point-of-care diagnostic technologies that support accurate antibiotic prescribing across a wide range of microbial infections. Before joining ID Genomics she was CEO of Xcede Technologies, Inc. and President of ProFibrix Inc. Her career also includes leadership and scientific roles at ZymoGenetics and Genentech Inc.

Elena Rechkina, Ph.D.

Director of Research and Development

LinkedIn

Dr. Rechkina brings broad scientific expertise in molecular biology and has spent more than 7 years in industrial R&D of PCR diagnostics and production quality control.
Over the past two years she has worked with the Department of Microbiology at the University of Washington, Seattle, and with ID Genomics, where she became a leader in qPCR-based clonotyping, whole genome sequencing and analysis, single nucleotide polymorphism detection and multi locus sequence typing.

Sandy Ryan, RAC

Director for Administrative and Quality Assurance/Regulatory Affairs
LinkedIn

Ms. Ryan has more than 12 years of experience across all phases of accounting, including administration of government grants and yearly and quarterly financial implementation, as well as oversight of quality and regulatory systems for a small IVD manufacturer. Her work has covered development of Design History Files, Technical Files, document control systems and Device Master records, and she has led FDA Inspections and ISO 13485 Audits.

Veronika Tchesnokova, MD, Ph.D.

Scientific Director

LinkedIn

Dr. Tchesnokova’s work spans developing and implementing study designs, reporting, overseeing data integrity and quality control measures, statistical analysis of clinical and experimental data, and advising on all scientific engagements of the organization. She is also a research scientist in Microbiology at the University of Washington – School of Medicine and has co-authored 59 peer-reviewed publications.